Skip to main content
. 2023 Feb 15;12(8):9202–9212. doi: 10.1002/cam4.5661

FIGURE 2.

FIGURE 2

Waterfall plot of changes in tumor maximum diameter in the overall cohort by combination therapy of lenvatinib plus anti‐programmed death‐1 antibodies. The target areas of tumors were examined in each patient and tumor response was assessed by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.